NG, KIU YAN CHARLOTTE
 Distribuzione geografica
Continente #
AS - Asia 2.739
NA - Nord America 2.150
SA - Sud America 558
EU - Europa 340
AF - Africa 64
OC - Oceania 8
Totale 5.859
Nazione #
US - Stati Uniti d'America 2.079
SG - Singapore 1.694
CN - Cina 475
BR - Brasile 465
VN - Vietnam 231
HK - Hong Kong 128
GB - Regno Unito 56
IT - Italia 55
DE - Germania 46
IN - India 44
FR - Francia 35
AR - Argentina 31
BD - Bangladesh 31
MX - Messico 30
RU - Federazione Russa 27
CA - Canada 22
ZA - Sudafrica 22
PL - Polonia 20
VE - Venezuela 19
EC - Ecuador 18
TR - Turchia 18
IQ - Iraq 16
NL - Olanda 15
FI - Finlandia 13
UZ - Uzbekistan 13
SA - Arabia Saudita 12
IE - Irlanda 11
JP - Giappone 11
ES - Italia 10
PH - Filippine 9
MA - Marocco 8
PK - Pakistan 8
CL - Cile 7
CZ - Repubblica Ceca 7
KE - Kenya 7
SE - Svezia 7
UA - Ucraina 7
AU - Australia 6
CR - Costa Rica 6
ID - Indonesia 6
NG - Nigeria 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DZ - Algeria 5
LB - Libano 5
LV - Lettonia 5
MY - Malesia 5
PY - Paraguay 5
BO - Bolivia 4
AM - Armenia 3
AZ - Azerbaigian 3
BE - Belgio 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LU - Lussemburgo 2
MG - Madagascar 2
NI - Nicaragua 2
PE - Perù 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TO - Tonga 1
Totale 5.857
Città #
Singapore 705
San Jose 406
Ashburn 378
The Dalles 285
Shanghai 243
New York 222
Dallas 144
Beijing 128
Hong Kong 124
Ho Chi Minh City 86
Hanoi 52
Los Angeles 46
São Paulo 42
Boardman 36
Santa Clara 24
Wilmington 20
Milan 19
Johannesburg 18
San Mateo 18
Orem 17
Warsaw 17
Brooklyn 16
Chennai 15
Munich 15
Da Nang 14
Rio de Janeiro 13
Tashkent 13
Helsinki 12
Frankfurt am Main 11
Mexico City 11
Tokyo 11
London 10
Belo Horizonte 9
Brasília 9
Paris 9
Seattle 9
Abbiategrasso 8
Ankara 8
Boston 8
Denver 8
Fortaleza 8
Guayaquil 8
Haiphong 8
Manchester 8
San Francisco 8
Atlanta 7
Council Bluffs 7
Dublin 7
Amsterdam 6
Baghdad 6
Brno 6
Campinas 6
Chandler 6
Dhaka 6
Goiânia 6
Lawrence 6
Nairobi 6
Princeton 6
Sydney 6
Buenos Aires 5
Fairfield 5
Guarulhos 5
Hải Dương 5
Maracaibo 5
Moscow 5
Phoenix 5
Poplar 5
Porto Alegre 5
Recife 5
Riga 5
Riyadh 5
Salvador 5
San José 5
Stockholm 5
Assago 4
Benin City 4
Casablanca 4
Chicago 4
Colombo 4
Curitiba 4
Erbil 4
Hangzhou 4
Istanbul 4
Jeddah 4
Joinville 4
Maceió 4
Natal 4
Piracicaba 4
Quito 4
Reston 4
Ribeirão Preto 4
Santa Cruz do Sul 4
Taboão da Serra 4
Ann Arbor 3
Araçatuba 3
Betim 3
Birmingham 3
Biên Hòa 3
Bragança Paulista 3
Brussels 3
Totale 3.538
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 95
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 69
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 62
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 60
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 60
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 60
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 59
Metaplastic breast carcinoma: more than a special type 59
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas 58
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 57
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 56
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 56
Prognostic signatures in breast cancer: correlation does not imply causation 55
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle 55
Breast cancer intra-tumor heterogeneity 55
Breast cancer intratumor genetic heterogeneity: causes and implications 55
Genomic landscape of adenoid cystic carcinoma of the breast 55
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 54
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 54
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 52
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 51
The Genomic Landscape of Male Breast Cancers 51
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 50
SCIM: universal single-cell matching with unpaired feature sets 50
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 49
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 49
The protein histidine phosphatase LHPP is a tumour suppressor 49
Genomic characterization of metastatic breast cancers 48
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 48
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 48
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 48
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 47
Genomic profiling of histological special types of breast cancer 47
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 46
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 46
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 46
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 46
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 46
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 46
Patient-derived xenografts and organoids model therapy response in prostate cancer 46
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 46
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 45
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 45
ESR1 and endocrine therapy resistance: more than just mutations 45
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 45
Chromosomal instability determines taxane response 44
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 44
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 44
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 44
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 44
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 43
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 43
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 43
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 43
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 42
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 42
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 42
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 42
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 42
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 42
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 42
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 42
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 41
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 41
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 41
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 41
SF3B1 mutations constitute a novel therapeutic target in breast cancer 41
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 41
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 41
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 41
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 41
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 41
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 40
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 40
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 40
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 40
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein 40
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 40
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 40
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 40
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 40
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion 40
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 40
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 39
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 39
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 39
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform 39
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 38
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas 38
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 38
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 38
Uterine adenosarcomas are mesenchymal neoplasms 38
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 38
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing 38
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures 37
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 37
Establishing standardized immune phenotyping of metastatic melanoma by digital pathology 37
Contralateral breast cancers: Independent cancers or metastases? 36
Siglec-7 represents a glyco-immune checkpoint on non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities 36
Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer 36
Totale 4.588
Categoria #
all - tutte 34.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 8 0 11
2021/202229 0 0 0 9 0 0 0 7 0 1 4 8
2022/202339 12 0 6 1 4 1 0 3 4 6 2 0
2023/2024765 1 3 4 2 0 342 54 56 14 9 111 169
2024/20251.469 28 5 7 18 11 168 85 89 317 420 156 165
2025/20263.657 613 340 158 369 125 249 1.203 211 177 212 0 0
Totale 6.006